Studies that examined the association between individual CSF biomarkers of AD and mortality have shown contrasting results; some have reported an association with CSF tau [18, 27] and hyperphosphorylated tau [17], while others did not find an association [18, 27, 28]. This evidence concerns the gene MAPT and Alzheimer disease.